MEKK3 was validated to be a target gene of miR-124m and the expression of MEKK3 was increased in a Parkinson’s disease model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Yao et al., 2018). This evidence concerns the gene MAP3K3 and Parkinson disease.